$NMRA Cashflow Statement | Understand Stock

$NMRA

$0.37 -$0.02 (6.31%) Close

$NMRA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Acquired in-process research and development
Stock-based compensation
Non-cash operating lease expense
Depreciation and amortization
Net accretion of investments in marketable securities
Impairment of held for sale assets
Loss on disposal of property and equipment
Amortization of debt issuance costs and accretion of final payment fee
Amortization and write-off of deferred debt issuance costs
Other noncash expenses
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Accounts payable
Accrued liabilities
Operating lease liabilities
Other assets
Net cash used in operating activities
Investing activities:
Purchases of marketable securities
Cash paid for acquisition of assets
Proceeds from sales and maturities of marketable securities
Proceeds from maturities of marketable securities
Purchases of property and equipment
Proceeds from sale of property and equipment
Net cash provided by (used in) investing activities
Financing activities:
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and commissions
Proceeds from term loan, net
Proceeds from exercise of stock options
Proceeds from employee stock purchase plan purchases
Proceeds from issuance of common stock
Repurchase of unvested early exercised shares
Payments for deferred offering costs
Proceeds from issuance of common stock in at-the-market transactions, net of commissions and offering costs
Net cash provided by financing activities
Net change in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash at beginning of year
Cash and cash equivalents and restricted cash at end of period
Components of cash and restricted cash:
Cash and cash equivalents
Restricted Cash
Total cash and cash equivalents and restricted cash
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of noncash investing and financing activities:
Acquisition of assets included in accounts payable and accrued liabilities
Purchases of property and equipment included in accounts payable
Conversion of preferred stock into common stock upon completion of initial public offering
Issuance of common stock upon achievement of milestone related to acquisition of assets
Principal amount of debt extinguished upon conversion to common stock
Debt issuance costs reclassified to equity in connection with conversion
Right-of-use-asset in connection with new operating lease agreement
Operating lease liability in connection with new lease agreement

Comments